Ezrin-derived peptides and pharmaceutical compositions thereof
The present invention relates to the field of medicine, specifically, to the field of chemical and pharmaceutical industry and concerns ezrin-derived peptides, in particular, a peptide comprising an amino acid sequence of general formula (I) X 1 EKKRRETVERE X 2 X 3 , wherein each X represents a non-polar amino acid residue. The use of the peptides as immunostimulatory agents, and more specifically, for use in treating and preventing antiviral, antibacterial and antifungal infections, and treatment of diseases of the GI tract, in particular ulcerative disorders of the GI tract. The present invention also relates to pharmaceutical compositions comprising the peptides. Further, the invention relates to methods of treatment of infection and ulcerative diseases of the GI tract comprising administering the peptides to patients in need thereof.
1. A peptide comprising an amino acid sequence of general formula (I)
X1EKKRRETVEREX2X3 (SEQ ID No:5)
wherein each of X1, X2 and X3 represent a non-polar amino acid residue.
2. The peptide as claimed in claim 1 , wherein the non-polar amino acid is independently selected from the group consisting of glycine, alanine, valine, leucine, methionine, isoleucine, proline, phenylalanine, tryptophan, and/or combinations thereof.
3. The peptide as claimed in claim 1 , wherein X1 X2 and/or X3 is glycine.
4. The peptide as claimed in claim 3 , wherein the amino acid sequence is GEKKRRETVEREGG (SEQ ID No: 1).
5. A pharmaceutical composition, comprising an effective amount of the peptide as claimed in claim 1 , and a pharmaceutically acceptable carrier or filler.
6. The pharmaceutical composition as claimed in claim 5 , further comprising an effective amount of the peptide according to SEQ ID No. 2 (TEKKRRETVEREKE).
7. The pharmaceutical composition as claimed in claim 5 , further comprising an effective amount of the peptide according to the SEQ ID No.3 (TEKKR).
8. The pharmaceutical composition as claimed in claim 5 , further comprising an effective amount of the peptide according to the SEQ ID No. 4 (RETVEREKE).
9. A method of stimulating an immune response in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of the peptide as claimed in claim 1 .
10. A method of stimulating an immune response in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of the pharmaceutical composition as claimed in claim 5 .